SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-24-079095
Filing Date
2024-06-28
Accepted
2024-06-28 16:31:39
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 achv_june_2024_s-3_refre.htm S-3 462015
2 EX-4.5 achv-ex4_5.htm EX-4.5 66357
3 EX-4.6 achv-ex4_6.htm EX-4.6 483386
4 EX-5.1 achv-ex5_1.htm EX-5.1 40689
5 EX-23.2 achv-ex23_2.htm EX-23.2 4473
6 EX-FILING FEES achv-exfiling_fees.htm EX-FILING FEES 39965
7 GRAPHIC img48573103_0.jpg GRAPHIC 4648
8 GRAPHIC img48573103_1.jpg GRAPHIC 4648
9 GRAPHIC img223336490_0.jpg GRAPHIC 17749
  Complete submission text file 0000950170-24-079095.txt   1135794
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-280585 | Film No.: 241086214
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)